InvestorsHub Logo
Followers 5
Posts 152
Boards Moderated 0
Alias Born 01/30/2014

Re: None

Thursday, 05/12/2022 6:23:32 PM

Thursday, May 12, 2022 6:23:32 PM

Post# of 717277
Only 5% of glio patients survive for five years. So how stunning is it for DCVAX-L to see life expectancy at 60 months rise from 5.7% to 13%, an increase of 228%. Some patients have seen total remission glio and are cancer free more than a decade after treatment. For example, Brad Silver participated in the Phase 1 trial 17 years ago and is cancer free now.

From:

https://eu.heraldtribune.com/story/business/2022/05/12/joan-lappin-northwest-bio-reports-promising-phase-3-results/9703043002/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News